Resmed Inc at William Blair Growth Stock Conference Transcript
Good afternoon, to everyone in the Midwest and the East Coast. Good morning, to the folks on the West Coast. My name is Margaret Kaczor. I'm the research analyst here at William Blair & Company who covers ResMed. I am required to inform you that you can obtain a complete list of research disclosures or potential conflicts of interest at williamblair.com.
Now first of all, thank you for everyone dialing in to the Blair conference. This is a name that we are featuring going into the conference. Because for us, ResMed is one of the best positioned companies we believe during and post COVID-19. The company has a wide range of products that are used to treat patients in hospital with the vent side, but also boasts one of the broadest digital platforms in all of MedTech, if not the broadest and also has a very, very healthy and large home health business.
So for us, this should allow them to weather the storm, better than their peers, while also benefiting from that accelerated move towards
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
